Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Furst

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
American Journal of Hematology|March 6, 2013
Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myelomaJean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Mediterranean Journal of Hematology and Infectious Diseases|September 25, 2015
Comparison of Three Distinct Prophylactic Agents Against Invasive Fungal Infections in Patients Undergoing Haplo-identical Hematopoietic Stem Cell Transplantation and Post-transplant CyclophosphamideJean El-Cheikh, Roberto Crocchiolo, Andrea Vai, et al.
Experimental Hematology|March 27, 2012
Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myelomaJean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Cancer|February 5, 2015
Unrelated cord blood compared with haploidentical grafts in patients with hematological malignanciesJean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Haematologica|August 27, 2016
Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemiaMohamad Mohty, Florent Malard, Didier Blaise, et al.
Blood Advances|December 22, 2020
Optimizing selection of double cord blood units for transplantation of adult patients with malignant diseasesGiancarlo Fatobene, Fernanda Volt, Frederico Moreira, et al.
European Journal of Haematology|March 6, 2012
Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myelomaJean El-Cheikh, Roberto Crocchiolo, Jean-Marie Boher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2013
CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignanciesEvgeny Klyuchnikov, Jean El-Cheikh, Andreas Sputtek, et al.
Haematologica|June 22, 2014
Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trialPatrice Chevallier, Myriam Labopin, Gérard Socié, et al.
Blood Advances|March 6, 2023
Impact of allele-level HLA matching on outcomes after double cord blood transplantation in adults with malignanciesGiancarlo Fatobene, Livia Mariano, Fernanda Volt, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
American Journal of Hematology|March 6, 2013
Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myelomaJean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Mediterranean Journal of Hematology and Infectious Diseases|September 25, 2015
Comparison of Three Distinct Prophylactic Agents Against Invasive Fungal Infections in Patients Undergoing Haplo-identical Hematopoietic Stem Cell Transplantation and Post-transplant CyclophosphamideJean El-Cheikh, Roberto Crocchiolo, Andrea Vai, et al.
Experimental Hematology|March 27, 2012
Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myelomaJean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Cancer|February 5, 2015
Unrelated cord blood compared with haploidentical grafts in patients with hematological malignanciesJean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Haematologica|August 27, 2016
Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemiaMohamad Mohty, Florent Malard, Didier Blaise, et al.
Blood Advances|December 22, 2020
Optimizing selection of double cord blood units for transplantation of adult patients with malignant diseasesGiancarlo Fatobene, Fernanda Volt, Frederico Moreira, et al.
European Journal of Haematology|March 6, 2012
Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myelomaJean El-Cheikh, Roberto Crocchiolo, Jean-Marie Boher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2013
CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignanciesEvgeny Klyuchnikov, Jean El-Cheikh, Andreas Sputtek, et al.
Haematologica|June 22, 2014
Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trialPatrice Chevallier, Myriam Labopin, Gérard Socié, et al.
Blood Advances|March 6, 2023
Impact of allele-level HLA matching on outcomes after double cord blood transplantation in adults with malignanciesGiancarlo Fatobene, Livia Mariano, Fernanda Volt, et al.
Pageof 5